Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XEROCELL: AD-SVF for Autoimmune Xerostomia
NCT05857358Phase 2Not yet recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jan 2024
- Primary completion
- Feb 2026
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of autologous adipose stromal vascular fraction in xerostomia, sponsored by Assistance Publique-Hôpitaux de Marseille. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT05857358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05857358.